CYTOSORBENTS CORPORATION (CTSO) Operating cash flow 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.4MFY2025 · since FY2016: -$6.7M → -$12.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.4M | +14.2% |
| FY2024 | -$14.4M | +33.4% |
| FY2023 | -$21.7M | +23.3% |
| FY2022 | -$28.2M | -101.6% |
| FY2021 | -$14.0M | -149.5% |
| FY2020 | -$5.6M | +66.5% |
| FY2019 | -$16.8M | -54.6% |
| FY2018 | -$10.8M | -67.8% |
| FY2017 | -$6.5M | +4.0% |
| FY2016 | -$6.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTSO financial trends
CTSO RevenueCTSO Net incomeCTSO Net marginCTSO Gross profitCTSO Gross marginCTSO Operating incomeCTSO Operating marginCTSO Free cash flowCTSO Capital expendituresCTSO Return on equityCTSO Stock buybacksCTSO Dividends paidCTSO Total assetsCTSO Total liabilitiesCTSO Shareholders’ equityCTSO overview →